MetLife files Form 144 reporting proposed stock sales

MetLife (proposed sales reported on Form 144) — Multiple affiliated accounts reported proposed sales of Common Stock via Form 144.

Rhea-AI Filing Summary

MetLife (proposed sales reported on Form 144) — Multiple affiliated accounts reported proposed sales of Common Stock via Form 144. The excerpt lists specific proposed sale entries with dates and amounts, including 121 shares for 04/02/2026 ($8,557.12), 144 shares for 05/05/2026 ($11,505.60), and other transactions through 06/18/2026.

The transactions are attributed to named accounts such as Separate Account, Separate Account II, Separate Account SPI, and MetLife 401k Plan Trust-Large Cap Equity Index. The filing lists broker and trade details for earlier sales and indicates cash sales in the past three months. This Form 144 disclosure notifies the market of proposed resale activity by related accounts.

Insights

Securities Compliance Counsel

TL;DR: Form 144 lists proposed sales by affiliated MetLife accounts with specific share and dollar entries.

Form 144 is a notice of proposed sale under securities law; it lists the accounts and proposed sale lines, including dates and numerical entries such as 121 shares ($8,557.12) on 04/02/2026 and multiple entries on 06/18/2026. These lines are administrative disclosures required when affiliates plan public resale.

Cash‑flow treatment and buyer details are not provided in the excerpt; subsequent filings or broker receipts would show completed transactions. Future SEC filings or broker confirmations would clarify execution and any impact on outstanding share counts.

Key Figures

Proposed sale - 04/02/2026: 121 shares Dollar amount - 04/02/2026: $8,557.12 Proposed sale - 05/05/2026: 144 shares +3 more

6 metrics

Proposed sale - 04/02/2026 121 shares 04/02/2026 line shows 121 shares and $8,557.12

Dollar amount - 04/02/2026 $8,557.12 Associated value for 121 shares on 04/02/2026

Proposed sale - 05/05/2026 144 shares 05/05/2026 line shows 144 shares and $11,505.60

Proposed sale - 06/18/2026 332 shares 06/18/2026 entry for MetLife 401k Plan Trust-Large Cap Equity Index shows 332 shares and $28,412.56

Aggregate example value - 06/18/2026 $28,412.56 Dollar figure tied to 332 shares on 06/18/2026

Other 06/18/2026 entries 276 shares ($23,620.08); 72 shares ($6,161.76); 19 shares ($1,626.02) Multiple account lines dated 06/18/2026 in the excerpt

Key Terms

Form 144, Separate Account II, MetLife 401k Plan Trust-Large Cap Equity Index

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Separate Account II financial

"Separate Account II 1 Metlife Way Whippany NJ 07981 | Common Stock"

MetLife 401k Plan Trust-Large Cap Equity Index financial

"MetLife 401k Plan Trust-Large Cap Equity Index 1 Metlife Way Whippany NJ 07981"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does MetLife's (MET) Form 144 filing indicate?

It indicates proposed resales of Common Stock by affiliated accounts. The filing lists specific entries such as 121 shares ($8,557.12) on 04/02/2026 and multiple sales dated through 06/18/2026, serving as a public notice of intended resale.

Which accounts are listed in the Form 144 for MET?

The excerpt lists accounts including Separate Account, Separate Account II, Separate Account SPI, and MetLife 401k Plan Trust-Large Cap Equity Index. Each account has dated sale lines with share and dollar figures tied to the proposed sales.

Are the listed sales in Form 144 completed transactions?

No; Form 144 is a notice of proposed sales, not proof of execution. The excerpt shows proposed sale dates and amounts; broker confirmations or subsequent filings would confirm whether each sale was completed.

What numeric details are shown for recent proposed sales in the excerpt?

The excerpt shows entries such as 121 shares ($8,557.12) on 04/02/2026, 144 shares ($11,505.60) on 05/05/2026, and 332 shares ($28,412.56) on 06/18/2026, among other dated lines.

Does the Form 144 state who will receive proceeds from these sales?

The excerpt lists the selling accounts and shows trade attributes (e.g., 'Cash') for some past sales, but it does not specify recipient parties for proceeds beyond identifying the accounts named in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/26/2026 - 04:12 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002027739
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	METLIFE INC
SEC File Number
Address of Issuer	200 Park Avenue New York NEW YORK 10016
Phone	212-578-2211
Name of Person for Whose Account the Securities are To Be Sold	Russell 1000 Value MetLife 401k Plan
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Affiliate discretionary manager

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Barclays 745 Seventh Ave New York NY 10019	288	24373.44	643436779	06/26/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	06/28/2013	Purchase	DEUTSCHE BANK			288	07/03/2013	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Separate Account 149 1 Metlife Way Whippany NJ 07981	Common Stock	04/02/2026	121	8557.12
Separate Account II 1 Metlife Way Whippany NJ 07981	Common Stock	05/05/2026	144	11505.6
Separate Account II 1 Metlife Way Whippany NJ 07981	Common Stock	05/28/2026	128	10490.88
MetLife 401k Plan Trust-Large Cap Equity Index 1 Metlife Way Whippany NJ 07981	Common Stock	06/18/2026	332	28412.56
Separate Account II 1 Metlife Way Whippany NJ 07981	Common Stock	06/18/2026	72	6161.76
Separate Account SPI 1 Metlife Way Whippany NJ 07981	Common Stock	06/18/2026	276	23620.08
Separate Account 149 1 Metlife Way Whippany NJ 07981	Common Stock	06/18/2026	19	1626.02

144: Remarks and Signature

Remarks
Date of Notice	06/26/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Mirsad Usejnoski
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)